Larissa Ranini Soares

Larissa Ranini Soares

Auto-generated profile, based on publicly available information

Larissa Ranini Soares

Escola de Ciências da Saúde e da Vida, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2025 in Hematology, Transfusion and Cell Therapy
Verified
Journal Article
Open access
MAMarina Chaves Amantéa
Marina Chaves Amantéa
RSRafaela Pires da Silva
Rafaela Pires da Silva
LSLarissa Ranini Soares
Larissa Ranini Soares
JPJoão Lorenzo de Medeiros Pereira
João Lorenzo de Medeiros Pereira
ASAna Paula Duarte De Souza
Ana Paula Duarte De Souza
CD36 is a glycoprotein associated with resistance to chemotherapy and the recurrence of acute myeloid leukemia. This systematic review aims to evaluate the impact of CD36 on the prognosis of acute myeloid leukemia, a complex heterogeneous malignant hematopoietic disease. The Embase, Scopus, Web of Science, Cochrane Library and SciELO databases were searched until September 2023. Only studies that analyzed CD36 expression in humans were included. Of 905 articles identified from the databases, 600 were screened and nine were included. The Newcastle-Ottawa Scale was used to evaluate the methodological quality of the studies. According to this systematic review, CD36 is associated with different prognostic factors in acute myeloid leukemia, including remission and relapse of the disease, overall survival, and chemoresistance.